^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    RBM38 overexpression

    i
    Other names: RBM38, RNA Binding Motif Protein 38, HSRNASEB, DJ800J21.2, SEB4D, RNPC1, RNA-Binding Region (RNP1, RRM) Containing 1, RNA-Binding Region-Containing Protein 1, CLL-Associated Antigen KW-5, SsDNA-Binding Protein SEB4, RNA-Binding Protein 38, Seb4B, RNA-Binding Motif Protein 38, SEB4B, SEB4
    Entrez ID:
    55544
    over2years
    RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5. (PubMed, Cancers (Basel))
    RBM38 is a novel therapeutic target that can reverse sorafenib resistance in HCC by combining and promoting the lncRNA GAS5.
    Journal
    |
    GAS5 (Growth Arrest Specific 5) • RBM38 (RNA Binding Motif Protein 38)
    |
    RBM38 overexpression
    |
    sorafenib
    4years
    RBM38 Mediates the Proliferation of Acute Myeloid Leukemia Cells HL-60 by Regulating FZD1 mRNA Stability (PubMed, Zhongguo Shi Yan Xue Ye Xue Za Zhi)
    RBM38 can regulate cell proliferation of HL-60 by improving the stability of FZD1 mRNA.
    Journal
    |
    RBM38 (RNA Binding Motif Protein 38)
    |
    RBM38 overexpression
    |
    dactinomycin